Member Articles

Dividend Increases/Decreases for the Week of February 23

by

Below we provide a list of firms that raised their dividends during the week ending February 23. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          ACE Aviation Holdings Inc. (ACAVF): now $0.16 per share dividend. Aker BP ASA (AKRBY): now $0.1738 per share quarterly dividend, was $0.1577. Allstate (ALL): now $0.92 per share quarterly dividend, was $0.89. AMERISAFE (ASMF): now $0.37 per share quarterly dividend, was $0.34. Analog Devices (ADI): now $0.92 per share quarterly dividend, was $0.86. Armada Hoffler Properties (AHH): now $0.205 per share quarterly dividend, was … Read more

Chemical Firms Continue to Worry About Economy; PPG Industries, Ecolab, and Eastman Chemical Stand Out in Second Quarter

by

The most common theme expressed by constituents in the chemicals (broad) industry during the calendar second quarter had to do with concerns about the economy. The negative tone was so prevalent that either management teams in the industry have started to engage in an executive form of “group think” or the economic environment continues to be difficult for many cyclical and largely commoditized chemical entities. Many industries, including housing, aerospace, and automotive, continue to perform well, but we think the latter interpretation of such commentary is likely correct: Albemarle (ALB): “an economic environment that saw continued sluggishness across Europe…and a much weaker China” Air Products (APD): “continued economic weakness…our outlook for the remainder of the fiscal year continues to be … Read more

Dividend Increases/Decreases for the Week of August 9

by

Below we provide a list of firms that raised their dividends during the week ending August 9. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          American States Water (AWR): now $0.4655 per share quarterly dividend, was $0.4300. AngloGold Ashanti (AU): now $0.22 per share interim dividend, was $0.19. Annaly Capital Management, Inc. PFD STK I 6.75% (NLY.PR.I): now $0.6761 per share quarterly dividend, was $0.4219. Ashtead Group plc (ASHTY): now $3.52 per share semi-annual dividend, was $0.58. Atlas Energy Solution (AESI): now $0.23 per share quarterly dividend, was $0.22. … Read more

Dividend Increases/Decreases for the Week of September 27

by

Below we provide a list of firms that raised their dividends during the week ending September 27. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          Acadia Realty Trust (AKR): now $0.19 per share quarterly dividend, was $0.18. Accenture (ACN): now $1.48 per share quarterly dividend, was $1.29. B3 S.A. – Brasil, Bolsa, Balcão (BOLSY): now $0.0214 per share quarterly dividend, was $0.0170. BancFirst (BANF): now $0.46 per share quarterly dividend, was $0.43. Bank of South Carolina (BKSC): now $0.19 per share quarterly dividend, was $0.17. Banco de Sabadell, S.A. … Read more

Dividend Increases/Decreases for the Week of January 24

by

Below we provide a list of firms that raised their dividends during the week ending January 24. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          Acuity Brands (AYI): now $0.17 per share quarterly dividend, was $0.15. Air Products and Chemicals (APD): now $1.79 per share quarterly dividend, was $1.77. Alliant Energy (LNT): now $0.5075 per share quarterly dividend, was $0.4800. Amalgamated Bank (AMAL): now $0.14 per share quarterly dividend, was $0.12. American Express (AXP): now $0.82 per share quarterly dividend, was $0.70. B&M European Value Retail S.A. (BMRRY): now … Read more

Dividend Increases/Decreases for the Week of August 1

by

Below we provide a list of firms that raised their dividends during the week ending August 1. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          American States Water (AWR): now $0.5040 per share quarterly dividend, was $0.4655. Ardmore Shipping (ASC): now $0.07 per share quarterly dividend, was $0.05. Artisan Partners Asset Management (APAM): now $0.73 per share quarterly dividend, was $0.68. AudioCodes (AUDC): now $0.20 per share semi-annual dividend, was $0.18. Banco Bradesco S.A. (BBDO): now $0.0021 per share monthly dividend, was $0.0019. The Bank of N.T. Butterfield & … Read more

Update: Frequently Asked Questions About Valuentum Securities, Inc.

by

What is Valuentum Securities? Valuentum (val∙u∙n∙tum) [val-yoo-en-tuh-m] Securities Inc. is an independent investment research publisher, offering premium equity reports and dividend reports, as well as commentary across all sectors/companies, a Best Ideas Newsletter (spanning market caps, asset classes), a Dividend Growth Newsletter, modeling tools/products, and more. Independence and integrity remain our core, and we strive to be a champion of the investor. Valuentum is based in the Chicagoland area. Valuentum is not a money manager, broker, or financial advisor. Valuentum is a publisher of financial information. How do I subscribe to Valuentum’s investment research services? 1)    Click the following link: signup-page. 2)    Select your membership plan. 3)    Enter your contact details. 4)    Click ‘Sign Up.’ 5)    Complete your purchase. 6)   Your payment profile may be recurring, so please check … Read more

January 5-9: The Week That Was – Drowning in Crude

by

By Brian Nelson, CFA The first full week of 2015 was a wild one! Monday and Tuesday brought some hefty losses to the indices, but the middle of the week helped recover most of the ground, only to give some of it back Friday. When all was said and done, however, the S&P 500 still closed comfortably above 2040, a huge leap from just 5-6 years ago. We’re still enjoying the good times, with economic data still coming in relatively sanguine. Like a frog in water, the markets are just waiting for the next shoe to drop, and the Federal Reserve is doing all that it can to assure investors that the Yellen-put is there to prop up the markets should … Read more

Consumer Staples: Product Pricing Gains To Wane in 2017?

by

Consumer staples giants Kimberly-Clark and Colgate-Palmolive are expecting product pricing growth to be less of a contributor in 2017. We think investors are wising up to the risks of consumer staples stocks, and increasing risk-free rates seem to already be complicating the investment decision-making process for many investors. Consumer staples equities in the S&P 500 are currently trading at ~19.4 times forward 12-month earnings, well above their sub-17 times 10-year trailing average. We believe investors will continue to swap out of these steady-eddy, but overpriced, gems in the near term, in favor of higher-beta commodity and energy-oriented companies as the market sets up to surge in 2017. We have been warning about the tipping point in Treasury yields and implications … Read more

How the FDA’s Delay of Baricitinib Impacts Eli Lilly and Incyte

by

Image Source: Paul Sableman The FDA dealt Eli Lilly and Incyte an unforeseen blow recently by rejecting their marketing application for Rheumatoid Arthritis candidate Baricitinib. Where does the duo go from here? By Alexander J. Poulos an Kris Rosemann The drug approval process is chock full of pitfalls, and until regulators give the final okay, anything can happen. The widely held consensus was Eli Lilly’s (LLY) and Incyte’s (INCY) marketing application for Rheumatoid Arthritis candidate Baricitinib would be approved, but the FDA shocked everyone by issuing a complete response letter requesting further data. Where does the duo of Eli Lilly and Incyte proceed from here? Baricitinib We were optimistic the FDA would approve Baricitinib for the indication of Rheumatoid Arthritis … Read more